ClinicalTrials.Veeva

Menu

Supporting Lifestyle Changes After Delivery (STELLA)

O

Oulu University Hospital

Status

Enrolling

Conditions

Obesity, Maternal
Lifestyle

Treatments

Device: Information and communication technology -based health behavior change support system

Study type

Interventional

Funder types

Other

Identifiers

NCT06241144
39/2023

Details and patient eligibility

About

Use of information and communication technology -based health behavior change support system in modifying lifestyle after delivery among women with obesity.

Full description

Postpartum weight retention is common and particular when accompanied with prior obesity, it further increases the risks of subsequent pregnancies and adverse effects on the long-term health.

The aim of this randomized controlled trial is to examine whether using an information and communication technology (ICT) -based health behavior change support system (HBCSS) reduce postpartum weight retention and disorders related to subsequent pregnancy. Web-based HBCSS application utilizes persuasive design and cognitive behavioral therapy.

200 participants with prepregnancy obesity (BMI ≥ 30.0 kg/m^2) and age ≥ 18 years are randomly assigned into two groups after delivery in the Oulu university hospital. The study period begins 5-12 weeks after delivery. All participants will have conventional postpartum lifestyle counselling and the intervention group get in addition access for 12 months to web-based HBCSS application, which is recommended to use twice a week for 5-10 minutes.

Participants are followed by questionnaires up to 24 months. The main outcome is weight change from baseline to 12 and 24 months. Medical records and national registers are used for long-term follow-up. Researchers have permission to contact participants afterwards. The ethical approval is permitted by the Regional Medical Research Ethics Committee of the Wellbeing Services County of North Ostrobothnia. The authorization for the use of medical device is granted from the Finnish Medicines Agency. Recruitment of the participants will be performed 2/2024-1/2026.

Enrollment

200 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pre-pregnancy BMI ≥ 30.0 kg/m^2
  • Smartphone user

Exclusion criteria

  • Eating disorder
  • Severe mental disorder
  • Use of other lifestyle support system or medication
  • Non-Finnish speaker

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

200 participants in 2 patient groups

Intervention
Experimental group
Treatment:
Device: Information and communication technology -based health behavior change support system
Control
No Intervention group

Trial contacts and locations

1

Loading...

Central trial contact

Sanna Mustaniemi, PhD; Elina Keikkala, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems